Activation of endoproteolytic processing of insulin-like growth factor-II in fetal, early postnatal, and pregnant rats and persistence of circulating levels in postnatal life

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4803-4811

  Qiu, Qing ^a   Jiang, Jin Yi ^a   Bell, Michael ^a   Tsang, Benjamin K ^a,b   Gruslin, Andrée ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEGLYCOSYLATION; DEVELOPMENT; FEMALE; FETUS DEVELOPMENT; MALE; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

AGING; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; FEMALE; FETUS; GLYCOSYLATION; INSULIN-LIKE GROWTH FACTOR II; MALE; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE HYDROLASES; PREGNANCY; PREGNANCY, ANIMAL; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34748841913     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0535     Document Type: Article

References (33)

1. Fowden AL 2003 The insulin-like growth factors and feto-placental growth. Placenta 24:803-812
2. Christofori G, Naik P, Hanahan D 1994 A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-418
3. Qiu Q, Basak A, Mbikay M, Tsang B, Gruslin A 2005 Role of proIGF-II processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci USA 102:11047-11052
4. Duguay SJ, Jin Y, Stein J, Duguay AN, Gardner P, Steiner DF 1998 Posttranslational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J Biol Chem 273:18443-18451
5. Valenzano KJ, Heath-Monnig E, Tollefsen SE, Lake M, Lobel P 1997 Biophysical and biological properties of naturally occurring high molecular weight insulin-like growth factor II variants. J Biol Chem 272:4804-4813
6. Khosla S, Ballard FJ, Conover CA 2002 Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis. J Clin Endocrinol Metab 87:3867-3870
7. Zumstein PP, Luthi C, Humbel RE 1985 Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc Natl Acad Sci USA 82:3169-3172
8. Hudgins WR, Hampton B, Burgess WH, Perdue JF 1992 The identification of O-glycosylated precursors of insulin-like growth factor II. J Biol Chem 267:8153-8160
9. Zapf J, Futo E, Peter M, Froesch ER 1992 Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90:2574-2584
10. Daughaday WH, Trivedi B 1992 Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 75:110-115
11. Hoekman K, van Doorn J, Gloudemans T, Maassen JA, Schuller AG, Pinedo HM 1999 Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma. Clin Endocrinol (Oxf) 51:247-253
12. Randhawa R, Cohen P 2005 The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 86:84-90
13. Han VK, Carter AM 2000 Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21:289-305
14. Brown AL, Graham DE, Nissley SP, Hill DJ, Strain AJ, Rechler MM 1986 Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. J Biol Chem 261:13144-13150
15. Stylianopoulou F, Herbert J, Soares MB, Efstratiadis A 1988 Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci USA 85:141-145
16. Holly JM 1998 The IGF-II enigma. Growth Horm IGF Res 8:183-184
17. Wolf E, Hoeflich A, Lahm H 1998 What is the function of IGF-II in postnatal life? Answers from transgenic mouse models. Growth Horm IGF Res 8:185-193
18. Moerth C, Schneider MR, Renner-Mueller I, Blutke A, Elmlinger MW, Erben RG, Camacho-Hubner C, Hoeflich A, Wolf E 2007 Postnatally elevated levels of insulin-like growth factor-II (IGF-II) fail to rescue the dwarfism of IGF-I deficient mice except kidney weight. Endocrinology 148:441-451
19. Hill DJ, Strutt B, Arany E, Zaina S, Coukell S, Graham CF 2000 Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets. Endocrinology 141:1151-1157
20. Sferruzzi-Perri AN, Owens JA, Pringle KG, Robinson JS, Roberts CT 2006 Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth. Endocrinology 147:3344-3355
21. Daughaday WH, Kapadia M, Mariz I 1987 Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. J Lab Clin Med 109:355-363
22. Schlumpf U, Heimann R, Zapf J, Froesch ER 1976 Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs. Acta Endocrinol (Copenh) 81:28-42
23. Espelund U, Bruun JM, Richelsen B, Flyvbjerg A, Frystyk J 2005 Pro- and mature IGF-II during diet-induced weight loss in obese subjects. Eur J Endocrinol 153:861-869
24. Strauss G, Christensen L, Zapf J 1994 Tumour-induced hypoglycaemia due to 'big' IGF-II. J Intern Med 236:97-99
25. Fukuda I, Hizuka N, Takano K, Asakawa-Yasumoto K, Shizume K, Demura H 1993 Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia. Endocr J 40:111-119
26. Moses AC, Nissley SP, Short PA, Rechler MM, White RM, Knight AB, Higa OZ 1980 Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. Proc Natl Acad Sci USA 77:3649-3653
27. Enjoh T, Hizuka N, Perdue JF, Takano K, Fujiwara H, Higashihashi N, Marumoto Y, Fukuda I, Sakano K 1993 Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in Western immunoblot analysis. J Clin Endocrinol Metab 77:510-517
28. Buchanan CM, Phillips AR, Cooper GJ 2001 Preptin derived from proinsulinlike growth factor II (proIGF-II) is secreted from pancreatic islet β-cells and enhances insulin secretion. Biochem J 360:431-439
29. Reznik SE, Fricker LD 2001 Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell Mol Life Sci 58:1790-1804
30. Daughaday WH, Kapadia M 1989 Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 86:6778-6782
31. van Doorn J, Hoogerbrugge CM, Koster JG, Bloemen RJ, Hoekman K, Mudde AH, Buul-Offers SC 2002 Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia. Clin Chem 48:1739-1750
32. Miraki-Moud F, Grossman AB, Besser M, Monson JP, Camacho-Hubner C 2005 A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. J Clin Endocrinol Metab 90:3819-3823
33. Mesiano S, Young IR, Browne CA, Thorburn GD 1988 Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors. J Endocrinol 119:453-460